VTP-194204

DB11806InvestigationalSmall molecule

Nrx194204 has been used in trials studying the treatment of Parkinson's Disease and Non-small Cell Lung Cancer.

Mechanism: Pharmacologically active on Human Retinoid X Receptors (RXRs)
Curator reviewed
Formula / weight: C₂₄H₃₂O₂ · 352.518 g/mol (avg)
Code names: AGN 194204 · IRX4204 · NRX194204 · VTP-194204

Resolves to

Compound

Structure

InChIKeyBOOOLEGQBVUTKC-NVQSDHBMSA-NSMILESC\C(\C=C\[C@@H]1C[C@]1(C)C1=CC=C2C(=C1)C(C)(C)CCC2(C)C)=C/C(O)=O

Targets

What you can answer from here — as of September 12, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with VTP-194204, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.